NCT03141736

Brief Summary

The purpose of this study is to determine whether the combination of Kangaroo Mother Care (KMC) as continuously as possible together with the use of a plastic bag in combination with routine World Health Organization (WHO) thermoregulation care reduces the incidence of moderate (32-36° C) or severe (\<32.0° C) hypothermia in preterm infants ≥ 32 to 36 6/7 weeks of gestational age (GA) when compared to KMC as continuously as possible together with routine WHO thermoregulation care.

Trial Health

15
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Nov 2024

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 3, 2017

Completed
2 days until next milestone

First Posted

Study publicly available on registry

May 5, 2017

Completed
7.5 years until next milestone

Study Start

First participant enrolled

November 19, 2024

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 12, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 12, 2025

Completed
Last Updated

December 16, 2025

Status Verified

November 1, 2022

Enrollment Period

11 months

First QC Date

May 3, 2017

Last Update Submit

December 8, 2025

Conditions

Keywords

InfantNewbornPretermHypothermiaKangarooPlasticBag

Outcome Measures

Primary Outcomes (2)

  • Moderate or severe hypothermia at 1 hour after birth (Phase 1A)

    Moderate (32.0-35.9C) or severe (\<32.0C) hypothermia at 1 hour after birth (via axillary temperature)

    1 hour after birth

  • Moderate or severe hypothermia at 24 hours or discharge (Phase 1B)

    Moderate (32.0-35.9C) or severe (\<32.0C) hypothermia at 24 hours or discharge whichever occurs first (via axillary temperature)

    1 to 24 hours after birth

Secondary Outcomes (13)

  • Any hypothermia at 1 hour after birth (Phase 1A)

    1 hour after birth

  • Any hypothermia at 24 hours or discharge (Phase 1B)

    1 to 24 hours or discharge

  • Hyperthermia at 1 hour after birth (Phase 1A)

    1 hour after birth

  • Hyperthermia at 24 hours or discharge (Phase 1B)

    1 to 24 hours or discharge

  • Skin rash

    1hour to 24 hours or discharge, or whichever occurs first

  • +8 more secondary outcomes

Study Arms (4)

KMC & WHO protocol (0-1 hour)

ACTIVE COMPARATOR

The combination of Kangaroo Mother Care (KMC) as continuously as possible together with routine World Health Organization (WHO) thermoregulation care (warm delivery rooms, immediate drying after birth, early and exclusive breastfeeding, postponement of bathing and weighing, and appropriate bundling.

Other: KMC & WHO protocol (0-1 hour)

KMC & WHO protocol (1-24 hours)

ACTIVE COMPARATOR

The combination of Kangaroo Mother Care (KMC) as continuously as possible together with routine World Health Organization (WHO) thermoregulation care (warm delivery rooms, immediate drying after birth, early and exclusive breastfeeding, postponement of bathing and weighing, and appropriate bundling.

Other: KMC & WHO protocol (1-24 hours)

KMC, WHO protocol & bag (0-1 hour)

EXPERIMENTAL

The combination of Kangaroo Mother Care (KMC) as continuously as possible together with the use of a plastic bag in combination with routine World Health Organization (WHO) thermoregulation care (warm delivery rooms, immediate drying after birth, early and exclusive breastfeeding, postponement of bathing and weighing, and appropriate bundling.

Other: KMC, WHO protocol & bag (0-1 hour)

KMC, WHO protocol & bag (1-24 hours

EXPERIMENTAL

The combination of Kangaroo Mother Care (KMC) as continuously as possible together with the use of a plastic bag in combination with routine World Health Organization (WHO) thermoregulation care (warm delivery rooms, immediate drying after birth, early and exclusive breastfeeding, postponement of bathing and weighing, and appropriate bundling.

Other: KMC, WHO protocol & bag (1-24 hours)

Interventions

WHO thermoregulation care - warm delivery rooms, immediate drying after birth, early and exclusive breastfeeding, postponement of bathing and weighing, and appropriate bundling

KMC & WHO protocol (0-1 hour)

In addition infants will be placed in a plastic bag (clear polyethylene non-medical low-cost \[3 cents per bag\]

KMC, WHO protocol & bag (0-1 hour)

WHO thermoregulation care - warm delivery rooms, immediate drying after birth, early and exclusive breastfeeding, postponement of bathing and weighing, and appropriate bundling

KMC & WHO protocol (1-24 hours)

In addition infants will be placed in a plastic bag (clear polyethylene non-medical low-cost \[3 cents per bag\]

KMC, WHO protocol & bag (1-24 hours

Eligibility Criteria

Age10 Minutes - 2 Hours
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Estimated gestational age ≥32 0/7 - 36 6/7 weeks
  • Delivery in the hospital

You may not qualify if:

  • Abdominal wall defect or myelomeningocele
  • Major congenital anomalies
  • Blistering skin disorder
  • Clinically unstable mothers secondary to cardiovascular and pulmonary conditions
  • Infants requiring respiratory support beyond 10 minutes after birth
  • Infant requiring NICU admission
  • C/section
  • Multiple gestation if the last delivering infant is not born within 10 minutes from the time of birth of the first infant

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Premature BirthHypothermia

Condition Hierarchy (Ancestors)

Obstetric Labor, PrematureObstetric Labor ComplicationsPregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesBody Temperature ChangesSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Colm P Travers, MD

    University of Alabama at Birmingham

    PRINCIPAL INVESTIGATOR
  • Waldemar A Carlo, MD

    University of Alabama at Birmingham

    STUDY DIRECTOR
0

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Model Details: Assignment
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD

Study Record Dates

First Submitted

May 3, 2017

First Posted

May 5, 2017

Study Start

November 19, 2024

Primary Completion

October 12, 2025

Study Completion

October 12, 2025

Last Updated

December 16, 2025

Record last verified: 2022-11

Data Sharing

IPD Sharing
Will not share